دورية أكاديمية
أعرض في EDS

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs

التفاصيل البيبلوغرافية
العنوان: Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs
المؤلفون: Emma C. de Moel, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl, Anne Schouffoer, Robbert J. Goekoop, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Georg Schett, Diane van der Woude
المصدر: Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-8 (2019)
بيانات النشر: BMC, 2019.
سنة النشر: 2019
المجموعة: LCC:Diseases of the musculoskeletal system
مصطلحات موضوعية: Calprotectin, S100A8/A9, MRP8/14, Rheumatoid arthritis, Disease activity, Diseases of the musculoskeletal system, RC925-935
الوصف: Abstract Objective To investigate whether calprotectin (S100A8/A9 or MRP8/14), an inflammatory complex released by monocytes, could indicate residual subclinical inflammation in rheumatoid arthritis (RA) patients who are in stable remission on disease-modifying anti-rheumatic drugs (DMARDs) and serve as a marker for disease flare after DMARD tapering. Methods We used data from two trials. Patients from the IMPROVED study had early (
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1478-6362
Relation: https://doaj.org/toc/1478-6362
DOI: 10.1186/s13075-019-2064-y
URL الوصول: https://doaj.org/article/dfd532bde6d54d069d499cc170fcfade
رقم الأكسشن: edsdoj.fd532bde6d54d069d499cc170fcfade
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14786362
DOI:10.1186/s13075-019-2064-y